🇺🇸 FDA
Patent

US 11168102

Bicyclic heteroaryl compounds and uses thereof

granted A61KA61K31/519A61K31/5377

Quick answer

US patent 11168102 (Bicyclic heteroaryl compounds and uses thereof) held by Revolution Medicines, Inc. expires Mon Nov 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Revolution Medicines, Inc.
Grant date
Tue Nov 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/519, A61K31/5377